David Kyne
Partner, FHS Capital Partners
David is a partner at FHS Capital Partners, an investment firm focused on early-stage professional service and technology businesses that deliver high-value niche expertise to chief communications and chief marketing officers. David is a healthcare communications specialist and founder of the KYNE communications agency. In addition to his role at FHS partners, David is co-founder of the Kyne Foundation, a non-profit with a focus on health and education in Africa and Europe, is co-founder of Resilience Action Network International, a global advocacy network focused on emerging health and climate threats and is Board Chair of Panorama Global, a social impact nonprofit based in Seattle.
Following a number of leadership roles at Hill & Knowlton and GCI Health (part of WPP) communications agencies in New York, David founded multi award-winning healthcare agency KYNE in 2009 with a focus on fostering global public-private partnerships in health working with foundations, government agencies, local health bodies and biopharmaceutical companies. As CEO of KYNE and later Evoke Kyne (following its acquisition by healthcare services company Inizio), David brought together multi-sector actors together to develop innovative communications programming across a number of health priorities. Under David’s leadership the company earned multiple industry awards including Global Healthcare Agency of the Year, PRWeek’s Healthcare Agency of the Year, Holmes EMEA Health Agency of the Year, PR News Top Places to Work and PRWeek Global Campaign of the Year for United Against Malaria, an initiative support by the Bill & Melinda Gates Foundation. In 2018, the Holmes Report named David to its EMEA Innovator 25 list and in 2020 David was named Healthcare Communicator of the Year by PMLiVE.
David earned a B.A. in history and politics from University College Dublin and a master’s degree in public relations from the Dublin Institute of Technology.
David lives in Dublin, Ireland with his wife and two adult sons.